Ovagen (Liver) – 20mg Peptide

Ovagen (Liver) – 20mg Peptide

Ovagen is a synthetic bioregulator tripeptide (sequence: Glu-Asp-Pro) specifically studied for its interaction with the liver and gastrointestinal tissues. It is investigated for its role in regulating protein synthesis and metabolic activity within hepatocytes. Researchers study Ovagen for its potential to support the structural and functional integrity of the liver, investigating its ability to modulate inflammatory responses and promote cellular repair following chemical or environmental stress.

Findings from early-stage clinical trials have reported:

• Improvements in liver function markers and enzymatic balance observed in experimental models.
• Enhanced rates of hepatocyte regeneration following toxin exposure reported in-vitro.
• Reductions in markers of lipid peroxidation and oxidative stress within liver tissue noted in-vivo.
• Observed stabilization of bile acid synthesis and cholesterol metabolism reported in research studies.

Researchers study Ovagen to investigate the biological pathways of liver protection and the regulation of metabolic gene expression. By analyzing its impact on cellular senescence within the hepatic system, it serves as a unique tool for understanding how bioregulator peptides can influence organ-specific longevity. This compound is a primary focus for research into chronic liver dysfunction and the preservation of systemic detoxification processes.

Available Formats:

This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use